Presenter: Dr. Tina Korownyk G. Michael Allan MD CCFP James McCormack BSc(Pharm) PharmD
In episode 483, James and Mike invite Tina to the podcast to talk about the aducanumab (Aduhelm) FDA approval story. We look at all the latest evidence, we talk about how people analyzed the data, whether or not the findings were clinically important, the side effects and finally the cost. And no matter how we…
This content is for *CFPC Member Rate, CFPC Member Rate, Non-CFPC Member Rate, and Resident members only.
Login Join Now
Login Join Now
Latest Podcasts
BS Medicine Episode #539: You have prostate cancer – now what?
In episode 539, James and Mike focus in a PREMIUM way on the latest prostate cancer intervention trial. Patients with prostate cancer were randomized to active monitoring, surgery, or radiotherapy…
BS Medicine Episode #538: Egging you on to look at the evidence around eggs
In episode 538, James and Mike discuss the great (but pretty much silly) egg controversy. We go over the best available evidence for eggs which is at best not great.…
BS Medicine Episode #537: A Jab for Your CAD: Influenza vaccination for the prevention of cardiovascular events
In episode 537, Mike and James invite Ricky Turgeon back to the podcast to talk about the impact of the influenza vaccination on cardiovascular events in both primary and secondary…
November 17, 2021
Presenter(s):
Dr. Tina Korownyk G. Michael Allan MD CCFP James McCormack BSc(Pharm) PharmD
Please provide any additional comments (optional).